Pharmaceutical distribution in Central Europe; changing legal environment

5 March 2013

In 2011, pharmaceutical distribution was liberalized in Central Europe, with Bulgaria making the on-line sale of medicines legal in March. 2012 brought the opposite trend. The Reimbursement Act in Poland imposed a ban on advertising by pharmacies, among other regulations which made the operational environment for most distribution concerns much harder.

News of the UK launch comes as the charity Diabetes UK issued its estimates that the number of people in Britain with some form of diabetes has passed three million for the first time. The figure rose by 132,000 in the past year alone. A further 850,000 people have the disease but don't know it, the charity said.

In addition, Hungary took steps to limit the ownership of pharmacies to pharmacists only and Slovakia no longer plans to allow non-pharmacy sales, according to the latest report of PMR, a Poland-based research and consulting company, entitled Distribution in Central Europe 2012. Comparative analysis of Poland, Hungary, Romania, the Czech Republic, Slovakia and Bulgaria.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical